These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 10852523

  • 1. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C, Eckel HE, Damm M, von Pritzbuer E, Kvasnicka HM.
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [Abstract] [Full Text] [Related]

  • 2. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
    Sittel C, Ruiz S, Kvasnicka HM, Volling P, Jungehülsing M, Eckel HE.
    Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C, Ruiz S, Volling P, Kvasnicka HM, Jungehülsing M, Eckel HE.
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.
    Cordes C, Münzel AK, Rudolph P, Hoffmann M, Leuschner I, Gottschlich S.
    Anticancer Res; 2009 Apr; 29(4):1459-65. PubMed ID: 19414402
    [Abstract] [Full Text] [Related]

  • 5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 6. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Jun; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
    Broich G, Lavezzi AM, Biondo B, Pignataro LD.
    In Vivo; 1996 Dec; 10(2):175-8. PubMed ID: 8744797
    [Abstract] [Full Text] [Related]

  • 12. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
    Calli C, Calli A, Pinar E, Oncel S, Demirtaşoğlu F.
    Kulak Burun Bogaz Ihtis Derg; 2005 Dec; 15(1-2):9-13. PubMed ID: 16340285
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy.
    Kamijo T, Yokose T, Hasebe T, Yonou H, Sasaki S, Hayashi R, Ebihara S, Miyahara H, Hosoi H, Ochiai A.
    Clin Cancer Res; 2000 Aug; 6(8):3159-65. PubMed ID: 10955798
    [Abstract] [Full Text] [Related]

  • 15. Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy.
    Ahmed WA, Suzuki K, Imaeda Y, Horibe Y.
    Auris Nasus Larynx; 2008 Jun; 35(2):213-9. PubMed ID: 17996416
    [Abstract] [Full Text] [Related]

  • 16. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H, Zhang M, Matsumoto S, Yamashita Y, Tanaka T, Tomoyose T, Takano H, Funaki K, Fukuyama H, Takahashi T, Sakoda S.
    J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
    [Abstract] [Full Text] [Related]

  • 17. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H, Fortin A, Bairati I, Morency R, Monteil RA, Têtu B.
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [Abstract] [Full Text] [Related]

  • 18. [Immunohistochemical markers of cell proliferation in laryngeal carcinoma].
    Urpegui García AM, Morandeira García MJ, Soria Navarro J, Rivas Rodríguez P, Valencia Julve J, Fernández Larripa S, Vallés Varela H.
    Acta Otorrinolaringol Esp; 2000 May; 51(4):279-87. PubMed ID: 10984949
    [Abstract] [Full Text] [Related]

  • 19. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 20. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
    Franchi A, Gallo O, Boddi V, Santucci M.
    Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.